Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registry.,Journal of Cardiovascular Electrophysiology

当前位置： X-MOL 学术 › J. Cardiovasc. Electrophysiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registry.
Journal of Cardiovascular Electrophysiology ( IF 2.3 ) Pub Date : 2020-05-26 , DOI: 10.1111/jce.14589
Iwona Gorczyca _{1,

2} , Anna Michalska ₂ , Magdalena Chrapek ₃ , Monika Budnik ₄ , Katarzyna Starzyk _{1,

2} , Olga Jelonek ₁ , Beata Uziębło-Życzkowska ₅ , Agnieszka Kapłon-Cieślicka ₄ , Monika Gawałko ₄ , Paweł Krzesiński ₅ , Agnieszka Jurek ₅ , Piotr Scisło ₄ , Janusz Kochanowski ₄ , Marek Kiliszek ₅ , Grzegorz Gielerak ₅ , Krzysztof J Filipiak ₄ , Grzegorz Opolski ₄ , Beata Wożakowska-Kapłon _{1,

2}

Affiliation

The prevalence and predictors of left atrial appendage thrombus (LAAT) in patients with non‐valvular atrial fibrillation (AF) who have been treated with non‐vitamin K antagonist oral anticoagulants (NOACs) are not well defined. We aimed to assess the occurrence and predictors of LAAT on transesophageal echocardiography (TOE) in patients with non‐valvular AF treated with NOACs for at least 3 weeks.

中文翻译：

在多中心注册管理机构中，采用非维生素K拮抗剂口服抗凝剂治疗的房颤患者左心耳血栓形成。

接受非维生素K拮抗剂口服抗凝剂（NOAC）治疗的非瓣膜性房颤（AF）患者的左心耳血栓（LAAT）的患病率和预测因素尚不明确。我们旨在评估经NOAC至少治疗3周的非瓣膜性房颤患者经食道超声心动图（TOE）发生LAAT的情况及其预测因素。

更新日期：2020-08-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11